Symbiotec Pharmalab Ltd.
Brookfield, RCom may revise mobile tower deal; Blackstone eyes Comstar
Canadian private investment firm Brookfield Infrastructure Partners is expected to lower the valuation of Reliance Communications Ltd’s tower business from ......
Actis invests $48M in drug manufacturer Symbiotec Pharmalab
Private equity firm Actis has invested $48 million (around Rs 295 crore) to pick a significant stake in Indore-based active ......
Recommended for you